Natera
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Natera and other ETFs, options, and stocks.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
CEOStephen Chapman
CEOStephen Chapman
Employees3,293
Employees3,293
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2003
Founded2003
Employees3,293
Employees3,293
NTRA Key Statistics
Market cap11.86B
Market cap11.86B
Price-Earnings ratio-25.52
Price-Earnings ratio-25.52
Dividend yield—
Dividend yield—
Average volume943.93K
Average volume943.93K
High today$97.76
High today$97.76
Low today$96.23
Low today$96.23
Open price$96.88
Open price$96.88
Volume161.65K
Volume161.65K
52 Week high$98.82
52 Week high$98.82
52 Week low$36.90
52 Week low$36.90
NTRA News
Yahoo Finance 4d
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc - Yahoo FinanceOn April 29, 2024, Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), sold 4,084 shares of the company. The transaction was filed on April 29, 2024,...
Yahoo Finance 5d
Natera to Report its First Quarter 2024 Results on May 9 - Yahoo FinanceAUSTIN, Texas, May 01, 2024--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will re...
Yahoo Finance 5d
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage - Yahoo FinanceBacked by large clinical validation study with over 650 RhD-negative patients with confirmed outcomes, resulting in 100% sensitivity and >99% specificity AUSTI...
Analyst ratings
89%
of 18 ratingsBuy
88.9%
Hold
5.6%
Sell
5.6%